First Horizon Advisors, Inc. Csl LTD Transaction History

First Horizon Advisors, Inc.

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$80.15 - $92.62 $22,041 - $25,470	-275 Reduced 90.46%	29 $2,000
Q2 2023 Aug 03, 2023	SELL	$91.49 - $104.64 $2,927 - $3,348	-32 Reduced 9.52%	304 $28,000
Q1 2023 May 15, 2023	SELL	$92.92 - $109.35 $1,765 - $2,077	-19 Reduced 5.35%	336 $32,000
Q4 2022 Feb 10, 2023	BUY	$84.9 - $102.89 $2,462 - $2,983	29 Added 8.9%	355 $34,000
Q3 2022 Nov 09, 2022	SELL	$90.51 - $207.38 $2,715 - $6,221	-30 Reduced 8.43%	326 $29,000
Q2 2022 Aug 02, 2022	BUY	$87.94 - $101.67 $31,306 - $36,194	356 New	356 $32,000
Q1 2022 May 10, 2022	SELL	$85.56 - $107.12 $32,598 - $40,812	-381 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$97.41 - $116.74 $2,143 - $2,568	22 Added 6.13%	381 $40,000
Q3 2021 Nov 15, 2021	SELL	$101.72 - $114.56 $624,662 - $703,512	-6,141 Reduced 94.48%	359 $37,000
Q3 2021 Nov 09, 2021	BUY	$101.72 - $114.56 $626,696 - $705,804	6,161 Added 1817.4%	6,500 $680,000
Q1 2021 May 11, 2021	BUY	$95.11 - $111.11 $8,179 - $9,555	86 Added 33.99%	339 $34,000
Q4 2020 Feb 11, 2021	BUY	$101.34 - $117.74 $5,877 - $6,828	58 Added 29.74%	253 $27,000
Q3 2020 Nov 12, 2020	BUY	$95.79 - $111.95 $11,303 - $13,210	118 Added 153.25%	195 $20,000
Q2 2020 Jul 31, 2020	BUY	$90.75 - $104.91 $6,987 - $8,078	77 New	77 $7,000
Q2 2019 Aug 05, 2019	SELL	$68.24 - $75.87 $4,026 - $4,476	-59 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$58.93 - $74.24 $4,066 - $5,122	-69 Reduced 53.91%	59 $0
Q1 2018 May 02, 2018	SELL	$54.51 - $65.8 $3,543 - $4,277	-65 Reduced 33.68%	128 $0
Q2 2017 Aug 14, 2017	BUY	N/A	193	193 $0

153K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $84.7B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.